Sopartec
Sopartec is the technology transfer and investment vehicle of the Université catholique de Louvain, founded in 1992 to commercialize university research through IP licensing, spin-off creation, and early-stage equity investment in UCLouvain-derived ventures.
- Company typePrivate
- Founded1992
- HeadquartersBel, Belgium
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Sopartec does
Sopartec is a Belgian technology transfer and investment company founded in 1992 and wholly owned by the Université catholique de Louvain (UCLouvain). The firm operates as the dedicated vehicle through which the university's research output is commercialized, evaluating, protecting, and licensing intellectual property generated within UCLouvain and supporting the creation of spin-off companies from the academic research base. Its primary constituency is the UCLouvain research community — faculty, doctoral researchers, and technology platforms — which supplies the underlying IP that Sopartec shepherds through patenting, licensing, and equity investment processes.
The company's core activity is spin-off creation and early-stage equity participation in ventures emerging from UCLouvain research. Sopartec works with academic inventors to assess commercial viability, secure patent protection, structure licensing agreements, and organize seed or Series A funding for nascent companies, frequently taking equity in lieu of or alongside cash fees. It also serves as a co-investment partner alongside external venture capital and corporate licensees who take downstream positions in UCLouvain-derived ventures. The technology base it works with spans the full breadth of UCLouvain's research output — life sciences, engineering, materials, ICT — and Sopartec's role is commercialization intermediation rather than primary technology development.
The business model is structurally different from a product or SaaS company. Revenue derives from a combination of equity upside on portfolio exits (IPO or trade sale of spin-offs), recurring licensing royalties on patented university IP, and service or management fees associated with the spin-off creation process. The firm operates with a small staff (1-10 employees) and is led by Philippe Durieux and Xavier Bastin as co-CEOs, with François Blondel as Director. Revenue cadence is inherently episodic — driven by exit and licensing events rather than contracted recurring streams — which is typical of mature university TTOs.
Sopartec firmographics
Firmographics- Name
- Sopartec
- Website
- https://sopartec.com
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Sopartec is the technology transfer and investment vehicle of the Université catholique de Louvain, founded in 1992 to commercialize university research through IP licensing, spin-off creation, and early-stage equity investment in UCLouvain-derived ventures.
- Ownership category
- akta.pro rank
Sopartec industry classification
Industry- Product category
- Technology Transfer and Research Commercialization Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)
- SIC
- Patent Owners & Lessors (6794), Investment Advice (6282)
- akta.pro primary industry
- Technology Transfer & Innovation-Driven Research Universities (High Commercialization) (EDAHABAH)
Keywords
Where Sopartec is headquartered
LocationHeadquarters
- HQ city
- Bel
- HQ country
- Belgium
- HQ region
- Europe
Markets served
Sopartec business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Others
Sopartec product offering
Product offeringCore offering
Sopartec is the technology transfer and investment arm of the Université catholique de Louvain. It supports the commercialization of university research by identifying, protecting, and licensing intellectual property, creating and funding spin-off companies, and managing equity investments in early-stage ventures emerging from UCLouvain's research base.
Product overview
No product information available. The source page displayed a verification/loading screen with no substantive company or product content.
Differentiator
Problem solved
Functional benefit
Companies that use Sopartec
Customer profileIdeal customer profiles1 record
Sopartec technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Sopartec partnerships and signals
Strategic signalRecent moves2 records
Sopartec competitors and assessment
Company assessmentBroad incumbents
- European Investment Fund (EIF): EIF is the EU's specialist provider of risk finance to SMEs and a major LP in European university-affiliated seed funds. It is a broad incumbent in the same ecosystem Sopartec operates in, often co-investing alongside TTO vehicles.
Direct peers
- Oxford University Innovation: Oxford University Innovation is the technology transfer and spin-out company of the University of Oxford. It operates the same TTO + equity model as Sopartec at significantly larger scale, making it a benchmark direct peer.
- Cambridge Enterprise: Cambridge Enterprise is the University of Cambridge's technology transfer office and seed investor. It is a leading European TTO with the same combination of licensing, spin-out creation, and fund management that Sopartec performs for UCLouvain.
- ETH transfer (ETH Zurich): ETH transfer is the technology transfer office of ETH Zurich, commercializing inventions and supporting spin-offs. It shares the same academic-TTO + equity mandate as Sopartec and is one of Europe's highest-performing university transfer offices.
- Gemma Frisius Fund: Gemma Frisius Fund is KU Leuven's seed and early-stage investment vehicle, founded by the university to invest in academic spin-offs. It mirrors Sopartec's dual TTO + investor mandate and is the most directly comparable Belgian peer.
- KU Leuven Research & Development (LRD): LRD is the technology transfer and spin-off creation office of KU Leuven, Belgium's other major research university. It is the closest direct peer to Sopartec in geography and operating model — TTO + equity participation in academic spin-offs.
- Imperial College Innovations (Imperial Enterprise): Imperial Enterprise handles technology transfer, licensing, and spin-out creation for Imperial College London. Like Sopartec, it combines IP commercialization with seed-stage equity investment in academic spin-offs.
Emerging players
- VIB (Flemish Institute for Biotechnology): VIB is a Belgian life sciences research institute with an active technology transfer and spin-off creation program. It is comparable to Sopartec as a Belgian academic research commercialization entity, though focused specifically on biotechnology.
Regional players
- Novalis Tech Transfer (Belgium): Novalis is a Belgian technology transfer and seed investment platform supporting academic life-science spin-offs. It overlaps with Sopartec in mandate and Belgian ecosystem presence.
- Université Paris-Saclay Technology Transfer Office: Université Paris-Saclay operates a technology transfer office that commercializes research from one of France's largest university clusters. It is comparable in function to Sopartec but operates in a different national market.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key highlights5 records
Customer concentration
Sopartec social profiles
Digital presenceSopartec financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sopartec leadership team
Management profileNumber of profiles
Profiles3 records
Sopartec funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sopartec M&A and investment
M&A and investmentM&A
Investments4 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sopartec
What does Sopartec do?
Sopartec is the technology transfer and investment arm of the Université catholique de Louvain. It supports the commercialization of university research by identifying, protecting, and licensing intellectual property, creating and funding spin-off companies, and managing equity investments in early-stage ventures emerging from UCLouvain's research base.
When was Sopartec founded?
Sopartec was founded in 1992. It employs 1 to 10 people.
Where is Sopartec based?
Sopartec is headquartered in Bel, Belgium, in the Europe region.
Who are Sopartec's main competitors?
European Investment Fund (EIF) is listed as a broad incumbent. Direct peers are Oxford University Innovation, Cambridge Enterprise, ETH transfer (ETH Zurich), Gemma Frisius Fund, KU Leuven Research & Development (LRD) and Imperial College Innovations (Imperial Enterprise). VIB (Flemish Institute for Biotechnology) is listed as an emerging player. Regional players are Novalis Tech Transfer (Belgium) and Université Paris-Saclay Technology Transfer Office.
Does Sopartec have an API?
No public API is recorded for Sopartec.
What industry is Sopartec in?
Sopartec's product category is Technology Transfer and Research Commercialization Services. Its primary akta.pro industry code is EDAHABAH, Technology Transfer & Innovation-Driven Research Universities (High Commercialization). Its NAICS code is 541715 and its SIC code is 6794.